Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study

INTRODUCTION. The incidence of colorectal neuroendocrine tumors (NETs) is increasing, and patients with this disease have particularly poor prognoses. Treatment options are limited, and survival times have not improved in the past decade. METHODS. A post hoc analysis of the efficacy and tolerability...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Castellano, Daniel, Bajetta, Emilio, Panneerselvam, Ashok, Saletan, Stephen, Kocha, Walter, O'Dorisio, Thomas, Anthony, Lowell B., Hobday, Timothy
פורמט: Artigo
שפה:Inglês
יצא לאור: AlphaMed Press 2013
נושאים:
Gastrointestinal Cancer
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3556255/
https://ncbi.nlm.nih.gov/pubmed/23263288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0263
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים